2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors

摘要

Compounds of the formula (I) are as defined in addition to pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation e.g. to treat cancer) effect in a warm-blooded animal, including humans.